2015年我国大陆有173种期刊被SCI数据库收录

2016-01-01 MedSci MedSci原创

SCI数据库中收录中国大陆（PEOPLES R CHINA）计有173种期刊被收录，相对2013年度的163种增加了10种(增幅为6.1%)。其中影响因子大于1.0的期刊由2013年度的66种增长至84种(增幅为27.3%)。其中排名第一，由Cell res变化为LIGHT-SCI APPL

目前，SCI数据库中收录中国大陆（PEOPLES R CHINA）计有173种期刊被收录，相对2013年度的163种增加了10种(增幅为6.1%)。其中影响因子大于1.0的期刊由2013年度的66种增长至84种(增幅为27.3%)。其中排名第一，由Cell res变化为LIGHT-SCI APPL。期刊收录数量的增加，多另外一侧面反应中国科技实力的提升，科研水平的提高。目前中国期刊的影响因子整体水平排在亚洲第一位。查询各个期刊详细信息可以看这里 //m.capotfarm.com/sci/

以下为影响因子大于1.0期刊的主要指标

	期刊名称	影响因子	被引频次	载文量
1	LIGHT-SCI APPL	14.603	1042	53
2	CELL RES	12.413	9195	80
3	NANO RES	7.010	5222	174
4	J MOL CELL BIOL	6.771	1141	42
5	FUNGAL DIVERS	6.221	2441	48
6	CELL MOL IMMUNOL	4.112	1744	58
7	CNS NEUROSCI THER	3.931	1745	110
8	TRANSPORTMETRICA	3.773	328	0
9	J GENET GENOMICS	3.585	1324	47
10	J INTEGR PLANT BIOL	3.335	2905	94
11	INT J DIGIT EARTH	3.291	603	54
12	PROTEIN CELL	3.247	1310	69
13	ACTA PHARMACOL SIN	2.912	6417	164
14	J PLANT ECOL	2.646	722	56
15	ASIAN J ANDROL	2.596	2260	125
16	INT J ORAL SCI	2.531	484	39
17	NEUROSCI BULL	2.509	869	95
18	TRANSPORTMETRICA B	2.417	33	13
19	J NAT GAS CHEM	2.398	1302	0
20	J ENERGY CHEM	2.352	314	108
21	ACTA BIOCH BIOPH SIN	2.191	2213	121
22	CHIN J CANCER	2.155	981	75
23	INSECT SCI	2.144	997	75
24	PARTICUOLOGY	2.110	1255	118
25	FRONT PHYS-BEIJING	2.086	392	71
26	J ENVIRON SCI-CHINA	2.002	6013	293
27	NANO-MICRO LETT	1.975	339	42
28	CHINESE J CATAL	1.964	2532	238
29	J DIGEST DIS	1.959	937	96
30	COMMUN COMPUT PHYS	1.943	1663	115
31	CHINESE J CANCER RES	1.935	442	92
32	J DIABETES	1.932	534	62
33	J MATER SCI TECHNOL	1.909	2650	200
34	INTEGR ZOOL	1.904	469	51
35	PROG NAT SCI-MATER	1.873	1801	94
36	CHIN OPT LETT	1.851	2018	278
37	CHINESE J POLYM SCI	1.835	1183	184
38	J THORAC DIS	1.783	1180	372
39	J SPORT HEALTH SCI	1.712	141	43
40	SCI CHINA CHEM	1.695	1756	208
41	SCI CHINA LIFE SCI	1.688	959	130
42	ACTA GEOL SIN-ENGL	1.682	2705	307
43	J ANIM SCI BIOTECHNO	1.681	186	55
44	BIOMED ENVIRON SCI	1.653	1543	80
45	RES ASTRON ASTROPHYS	1.640	830	140
46	J BIONIC ENG	1.632	741	60
47	CHINESE PHYS B	1.603	8091	1281
48	CURR ZOOL	1.594	652	76
49	PETROL EXPLOR DEV+	1.592	1007	101
50	CHINESE CHEM LETT	1.587	3843	377
51	CHINESE SCI BULL	1.579	10429	632
52	CHINESE J CHEM	1.578	3066	177
53	HEPATOB PANCREAT DIS	1.517	1396	84
54	PEDOSPHERE	1.500	1633	82
55	SCI CHINA EARTH SCI	1.491	1475	277
56	J SYST EVOL	1.488	715	71
57	ADV ATMOS SCI	1.479	2082	128
58	ACTA PETROL SIN	1.455	5799	279
59	ACTA CHIM SINICA	1.426	2453	147
60	J GERIATR CARDIOL	1.395	219	54
61	FRONT ENV SCI ENG	1.357	576	104
62	ENDOSC ULTRASOUND	1.353	79	34
63	J GEOGR SCI	1.344	938	77
64	TRANSPORTMETRICA A	1.333	77	46
65	CHINESE PHYS C	1.313	998	228
66	BONE RES	1.310	40	20
67	INT J SEDIMENT RES	1.306	535	46
68	J ZHEJIANG UNIV-SC B	1.278	1637	115
69	J RARE EARTH	1.261	2808	179
70	WORLD J PEDIATR	1.236	485	59
71	CHIN J INTEGR MED	1.217	822	133
72	SCI CHINA TECHNOL SC	1.192	1843	286
73	T NONFERR METAL SOC	1.178	5357	521
74	SCI CHINA PHYS MECH	1.143	1470	293
75	APPL MATH MECH-ENGL	1.128	1331	125
76	ACTA METEOROL SIN	1.116	1087	0
77	CHIN J NAT MEDICINES	1.114	578	138
78	CHINESE J CHEM ENG	1.098	1902	193
79	CHINESE J AERONAUT	1.070	908	175
80	ASIAN PAC J TROP MED	1.062	799	191
81	CHINESE MED J-PEKING	1.053	6666	710
82	BUILD SIMUL-CHINA	1.029	238	55
83	RARE METALS	1.009	993	124
84	FRONT MATER SCI	1.000	113	42

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (20)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-26 doctording1

是一篇不错的文章

158 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-26 doctording1

这篇文章有一定深度

166 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-26 doctording1

了解一下，说不定以后有用

164 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-05 xiaotaiyang1

了解了

195 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-04 1de22f07m68(暂无匿称)

还需继续进步

170 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-03 lu2996

学术造假越少才是真正的进步

117 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-03 lu2996

支持

122 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-02 liushui8012

医学请单列

190 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-02 chen13

最好把医学类单列

117 0
[GetPortalCommentsPageByObjectIdResponse(id=59884, encodeId=6ad059884d6, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59883, encodeId=d5bf598839c, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 17:06:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59529, encodeId=9ae059529dd, content=了解一下，说不定以后有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:51:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51921, encodeId=fd0e519219c, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Tue Jan 05 00:26:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51640, encodeId=f4c0516408a, content=还需继续进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=122f1676201, createdName=1de22f07m68(暂无匿称), createdTime=Mon Jan 04 08:47:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51345, encodeId=0c1451345e1, content=学术造假越少才是真正的进步, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51344, encodeId=17df513447d, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1b91651063, createdName=lu2996, createdTime=Sun Jan 03 03:57:00 CST 2016, time=2016-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51254, encodeId=d66f51254a3, content=医学请单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150714/IMG55A4BC357ED6E1444.jpg, createdBy=9f231612624, createdName=liushui8012, createdTime=Sat Jan 02 20:34:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51214, encodeId=e48551214ca, content=最好把医学类单列, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a299105, createdName=chen13, createdTime=Sat Jan 02 17:03:00 CST 2016, time=2016-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51213, encodeId=18dd51213d3, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc9a1675161, createdName=樱桃树, createdTime=Sat Jan 02 16:30:00 CST 2016, time=2016-01-02, status=1, ipAttribution=)]
2016-01-02 樱桃树

厉害

112 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

报道

2015年我国大陆有173种期刊被SCI数据库收录

相关资讯

科室

工具

服务